Linezolid Pharmacokinetics in Critically Ill Patients: Continuous Versus Intermittent Infusion
Background: Linezolid has been found to have considerable interindividual variability, especially in critically ill patients, which can lead to suboptimal plasma concentration. To overcome this shortcoming, several solutions have been proposed. These include using loading dose, higher maintenance do...
Saved in:
Main Authors: | Ligia-Ancuța Hui (Author), Constantin Bodolea (Author), Adina Popa (Author), Ana-Maria Vlase (Author), Elisabeta Ioana Hirișcău (Author), Laurian Vlase (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Linezolid Administration to Critically Ill Patients: Intermittent or Continuous Infusion? A Systematic Literature Search and Review
by: Ligia-Ancuta Hui, et al.
Published: (2022) -
Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges
by: Ahmed E. Abou Warda, et al.
Published: (2022) -
Outcomes of Intravenous Push versus Intermittent Infusion Administration of Cefepime in Critically Ill Patients
by: Susan E. Smith, et al.
Published: (2023) -
Cefepime extended infusion versus intermittent infusion: Clinical and cost evaluation
by: Aalok V. Khole, et al.
Published: (2023) -
Investigation of a Potential Pharmacokinetic Interaction Between Nebivolol and Fluvoxamine in Healthy Volunteers
by: Ana-Maria Gheldiu, et al.
Published: (2017)